abstract |
The present invention relates to antibodies that bind to 5T4, including bispecific antibodies that bind to 5T4 and CD3. The invention further provides pharmaceutical compositions comprising such antibodies and the use of such antibodies for therapeutic and diagnostic procedures, particularly in cancer therapy. |